Biden, China and America’s vaccine edge

First, a waiver for COVID-19 vaccines will obviously decrease the incentive for companies to make vaccines for the next disease. … Second, a TRIPs waiver will eliminate the most important of the barriers to China making sophisticated vaccines: patent protection. Reuters reports that the Biden administration does not want a waiver to aid the Chinese pharmaceutical industry and believes it can address this issue “through the WTO negotiations,” but unfortunately it “did not specify how.”